Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

71.92
-1.3300-1.82%
Post-market: 71.920.00000.00%19:30 EDT
Volume:580.54K
Turnover:42.01M
Market Cap:1.65B
PE:15.84
High:74.99
Open:73.54
Low:71.56
Close:73.25
52wk High:99.50
52wk Low:70.15
Shares:22.97M
Float Shares:20.28M
Volume Ratio:1.29
T/O Rate:2.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.77
PE(LYR):21.66

Loading ...

Update: ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; Lifts 2026 Outlook

MT Newswires Live
·
May 08

GUIDANCE: (ANIP) ANI Pharmaceuticals Expects 2026 Adjusted EPS Range $9.19 to $9.69, vs. FactSet Est of $9.07

MT Newswires Live
·
May 08

Stock Track | ANI Pharmaceuticals Soars 5.35% in Pre-market on Strong Earnings Beat, Raised Guidance and $100M Buyback

Stock Track
·
May 08

ANI Pharma Q1 FY26 net income rises 93.1% to USD 29.5 million; revenue increases 20.5% to USD 237.5 million

Reuters
·
May 08

BRIEF-ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3

Reuters
·
May 08

ANI Pharmaceuticals Q1 EPS USD 1.28

THOMSON REUTERS
·
May 08

ANI Pharmaceuticals Q1 Adjusted Ebitda USD 63 Million

THOMSON REUTERS
·
May 08

ANI Pharmaceuticals Inc: $100 Mln Share Repurchase Program Authorized by Board of Directors

THOMSON REUTERS
·
May 08

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

THOMSON REUTERS
·
May 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08

Earning Preview: ANI Pharmaceuticals this quarter’s revenue is expected to increase by 14.88%, and institutional views are bullish

Earnings Agent
·
May 01

ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET

GlobeNewswire
·
Apr 24

ANI Pharmaceuticals Secures FDA Approval for Generic Orap

MT Newswires Live
·
Apr 20

ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity

GlobeNewswire
·
Apr 20

Assessing ANI Pharmaceuticals (ANIP) Valuation After Recent Mixed Share Price Performance

Simply Wall St.
·
Apr 18

ANI Pharma General Counsel Meredith Cook disposes 500 common shares worth $38,975

Reuters
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune

Reuters
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma

Reuters
·
Apr 13

ANI Pharmaceuticals Launches Generic Carbamazepine Capsules in US

MT Newswires Live
·
Apr 13

BUZZ-ANI Pharmaceuticals rises on US launch of generic epilepsy drug

Reuters
·
Apr 13